2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O19] Oral Session 19　Translational Research / Clinical Pharmacology
【E】

Sat. Feb 19, 2022 8:20 AM - 9:50 AM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Yuichi Ando（Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital），Yataro Daigo（Department of Medical Oncology and Cancer Center / Center for Antibody and Vaccine Therapy, Institute of Medical Science, Shiga University of Medical Science / The University of Tokyo）
Discussant：Shunsuke Kondo（Department of Experimental Therapeutics, National Cancer Center Hospital）

[O19-3] Deficiency of splicing factor RBM10 limits EGFR-TKI response in metastatic EGFR mutant lung cancer

○Shigeki Nanjo1,2, Ross Okimoto2, Seiji Yano1, Trever Bivona2 (1.Division of Medical Oncology, Kanazawa University Cancer Research Institute, 2.Division of Hematology/ Oncology, University of California San Francisco)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password